Go Deep
Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,071 | -26.8 | 6.59 | 0.02 | 639.02 |
| Oct 2026 | 20,317 | -25.9 | 6.36 | 0.02 | 614.31 |
| Oct 2026 | 20,388 | -26.7 | 6.29 | 0.02 | 607.75 |
| Oct 2026 | 20,618 | -24.3 | 5.97 | 0.02 | 575.87 |
| Oct 2026 | 20,608 | -24.4 | 5.98 | 0.02 | 577.43 |
| Oct 2026 | 20,524 | -24.7 | 6.06 | 0.02 | 585.02 |
| Oct 2026 | 20,806 | -23.6 | 5.80 | 0.02 | 558.03 |
| Oct 2026 | 20,847 | -23.4 | 5.76 | 0.02 | 553.13 |
Gyre Therapeutics, Inc. Quarterly Results
Quarterly data isn't available for this company right now.
Gyre Therapeutics, Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
Gyre Therapeutics, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Gyre Therapeutics, Inc. owed $0.28 for every $1 it owned in Jun 2026, up from $0.15 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.28× | 0.14× | 0.22× | 0.88× | 0.15× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Gyre Therapeutics, Inc. Cash Flow
Cash flow data isn't available for this company right now.